What are the treatments for cholangiocarcinoma? There are many treatments

The early symptoms of cholangiocarcinoma are not very obvious and can be easily ignored by patients. By the time they are discovered, they are already in the middle or late stages. DC-CIK biological immunotherapy and surgical resection are options for patients, but they need to be decided based on their condition. At the same time, patients also need to pay attention to related matters after surgery. Their daily routine and diet are closely related to the disease.

Everyone knows that cancer is terrible and no one wants to get cancer because of themselves or some other reasons. However, some people do not pay much attention to their health. When they have a physical examination, they are diagnosed with cancer and their health is affected. Cholangiocarcinoma is such a disease. So what are the treatments for cholangiocarcinoma?
Cholangiocarcinoma is a type of primary liver cancer. Clinically, it has a lower incidence than hepatocellular carcinoma, and there are generally no contraindications to surgery for cholangiocarcinoma. The current treatment option for cholangiocarcinoma is to use surgery to control the disease. Depending on their condition, patients should first consider radical surgical resection, including local liver lobe or liver segment resection, which is an effective way to improve survival. After surgery, it can also be decided whether to give postoperative auxiliary systemic chemotherapy or hepatic artery embolization chemotherapy based on the patient's own condition and specific pathological type.
DC-CIK biological immunotherapy is currently widely used in clinical practice as the fourth mode of tumor treatment. Cholangiocarcinoma is a rare malignant tumor with no obvious symptoms in the early stage. It is usually in the late stage after being discovered, so patients need to pay attention. Even in the early stage of cholangiocarcinoma, cholangiocarcinoma is prone to early lymph node metastasis and high recurrence rate after surgery. Therefore, actively exploring various comprehensive treatment measures for cholangiocarcinoma in order to improve the efficacy of cholangiocarcinoma has become the focus of attention of clinicians. It plays an unprecedented role in the comprehensive treatment of tumors. The combined action of DC cells and CIK cells can enhance the patient's own immune ability, kill cancer cells, prevent the spread and recurrence of cancer cells, and at the same time improve the patient's quality of life and prolong the patient's survival.
Cholangiocarcinoma is no longer suitable for surgical treatment in the late stage, because the cancer cells of patients with late stage cholangiocarcinoma have spread and metastasized. At this time, surgical treatment is not very meaningful. Therefore, it is not recommended to use surgery to treat the patient's disease in the late stage. The main treatment for patients with advanced cholangiocarcinoma is chemotherapy and radiotherapy, which can control the progression of the disease.